Defining seroprevalence and correlates of protection for Neisseria meningitidis group A in the African meningitis belt
非洲脑膜炎带 A 组脑膜炎奈瑟菌的血清流行率和保护相关性的定义
基本信息
- 批准号:G0701269/1
- 负责人:
- 金额:$ 26.72万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2008
- 资助国家:英国
- 起止时间:2008 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We are trying to find out more about the factors that protect people against meningitis caused by bacteria known as ‘group A meningococcus’. Large, devastating epidemics of this disease occur in Africa in a sub-Saharan region called the ‘meningitis belt’. A vaccine is being developed against this disease, and will be first used in Burkina Faso in 2009.People who are vaccinated produce antibodies in their blood that protect them from this form of meningitis. We also know that some individuals can develop antibodies naturally if they are exposed to the bacteria during the course of their life. Although we can measure these antibodies we do not know what levels are needed for protection. To study this, we are going to take blood samples from unvaccinated individuals in Burkina Faso and compare the proportion of people in different age groups who have antibodies above a certain threshold with their chances of getting meningitis. If we can define this marker of protection, we will help scientists address other important questions, such as how often populations should be vaccinated to maintain protection against the disease. In addition, we will create a collection of blood samples that can be used by other researchers to study other types of meningitis in Africa.
我们正试图找出更多的因素,保护人们免受脑膜炎所造成的细菌称为'组脑膜炎球菌'。这种疾病在非洲撒哈拉以南地区发生了大规模、毁灭性的流行,该地区被称为“脑膜炎带”。一种针对这种疾病的疫苗正在开发中,并将于2009年在布基纳法索首次使用。接种疫苗的人在血液中产生抗体,保护他们免受这种脑膜炎的侵害。我们还知道,有些人可以开发抗体自然,如果他们暴露于细菌在他们的生活过程中。虽然我们可以测量这些抗体,但我们不知道需要什么水平的保护。为了研究这一点,我们将从布基纳法索未接种疫苗的人身上采集血液样本,并将不同年龄组中抗体超过一定阈值的人的比例与他们患脑膜炎的几率进行比较。如果我们能够定义这种保护标记,我们将帮助科学家解决其他重要问题,例如人群应该多久接种一次疫苗以保持对疾病的保护。此外,我们还将收集血液样本,供其他研究人员用于研究非洲其他类型的脑膜炎。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caroline Trotter其他文献
Validation and use of a serum bactericidal antibody assay for <em>Neisseria meningitidis</em> serogroup X in a seroprevalence study in Niger, West Africa
- DOI:
10.1016/j.vaccine.2022.08.013 - 发表时间:
2022-10-06 - 期刊:
- 影响因子:
- 作者:
Sara Katz;Kelly Townsend-Payne;Jennifer Louth;Lisa Lee-Jones;Caroline Trotter;Ibrahim Dan Dano;Ray Borrow; MenAfriCar Consortium - 通讯作者:
MenAfriCar Consortium
Group B streptococcus infection during pregnancy and infancy: Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden estimates of regional and global burden
妊娠期和婴儿期 B 族链球菌感染:妊娠期和婴儿期 B 族链球菌感染:区域和全球负担估计 区域和全球负担估计
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Bronner P Gonçalves;S. Procter;Proma Paul;Jaya Chandna;Alexandra Lewin;Farah Seedat;A. Koukounari;Z. Dangor;S. Leahy;S. Santhanam;Hima B John;Justina Bramugy;Azucena Bardají;Amina Abubakar;Carophine Nasambu;R. Libster;Clara Sánchez Yanotti;E. Horváth;Henrik T Sørensen;Diederik van de Beek;M. Bijlsma;William M Gardner;N. Kassebaum;Caroline Trotter;Quique Bassat;Shabir Madhi;P. Lambach;Mark Jit;S. Yanotti;Gardner Mph;Catalan;P. DrBronner;Gonçalves;Patrick Vidzo - 通讯作者:
Patrick Vidzo
Hospital admissions in drug-users for skin and soft tissue infections and vascular disorders: geographical distribution in England, April 2001 to March 2006
- DOI:
10.1016/j.jinf.2007.04.097 - 发表时间:
2007-09-01 - 期刊:
- 影响因子:
- 作者:
Charles Irish;Roy Maxwell;Mark Dancox;Paul Brown;Caroline Trotter;Julia Verne;Mary Shaw - 通讯作者:
Mary Shaw
Health impact of routine immunisation service disruptions and mass vaccination campaign suspensions caused by the COVID-19 pandemic: Multimodel comparative analysis of disruption scenarios for measles, meningococcal A, and yellow fever vaccination in 10 low- and lower middle-income countries
COVID-19 大流行造成常规免疫服务中断和大规模疫苗接种活动暂停对健康的影响:对 10 个低收入和中低收入国家麻疹、A 型脑膜炎球菌和黄热病疫苗接种中断情景的多模型比较分析
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
K. Gaythorpe;K. Abbas;J. H. Huber;A. Karachaliou;N. Thakkar;Kim Woodruff;Xiang Li;Susy Echeverría;Matthew J. Ferrari;Michael L. Jackson;Kevin McCarthy;Alex Perkins;Caroline Trotter;M. Jit - 通讯作者:
M. Jit
Another step towards defeating meningitis
迈向战胜脑膜炎的又一步
- DOI:
10.1016/s0140-6736(25)00196-5 - 发表时间:
2025-03-29 - 期刊:
- 影响因子:88.500
- 作者:
Caroline Trotter;Kanny Diallo - 通讯作者:
Kanny Diallo
Caroline Trotter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caroline Trotter', 18)}}的其他基金
Mathematical Modelling for Infectious Disease Dynamics and Control in East Africa (MMIDD-EA)
东非传染病动态和控制的数学模型 (MMIDD-EA)
- 批准号:
EP/T003650/1 - 财政年份:2020
- 资助金额:
$ 26.72万 - 项目类别:
Research Grant
相似海外基金
Middle East Respiratory Syndrome (MERS) seroprevalence in zoonotic reservoirs and in humans: implications for spillover risk and population underlying infection
中东呼吸综合征 (MERS) 在人畜共患宿主和人类中的血清流行率:对溢出风险和潜在感染人群的影响
- 批准号:
495102 - 财政年份:2023
- 资助金额:
$ 26.72万 - 项目类别:
Operating Grants
Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness / Implementation Hybrid Study
遏制尼日利亚青少年艾滋病毒流行的强化组合方法 (iCARE) 加上有效性/实施混合研究
- 批准号:
10749347 - 财政年份:2023
- 资助金额:
$ 26.72万 - 项目类别:
FOYC+ImPACT US: A digital platform for critical sexual health risk reduction curriculum customization and hybrid/remote delivery of Focus on Youth to underserved Caribbean youth in the U.S.
FOYC ImPACT US:一个数字平台,用于关键的性健康风险降低课程定制以及混合/远程向美国服务不足的加勒比青年提供“关注青年”课程。
- 批准号:
10699553 - 财政年份:2023
- 资助金额:
$ 26.72万 - 项目类别:
Sex differences of COVID-19 serological response of individuals infected, vaccinated, or those with hybrid immunity in Ontario.
安大略省感染者、疫苗接种者或具有混合免疫力的个体的 COVID-19 血清学反应的性别差异。
- 批准号:
486241 - 财政年份:2022
- 资助金额:
$ 26.72万 - 项目类别:
Studentship Programs
Drug, microbiome, and immune determinants of birth and neurodevelopmental outcomes in children with exposure to HIV infection
HIV感染儿童出生和神经发育结果的药物、微生物组和免疫决定因素
- 批准号:
10381032 - 财政年份:2022
- 资助金额:
$ 26.72万 - 项目类别:
A longitudinal seroprevalence survey of SARS-CoV-2 infection among health care workers and children
医护人员和儿童中 SARS-CoV-2 感染的纵向血清流行率调查
- 批准号:
21K17271 - 财政年份:2021
- 资助金额:
$ 26.72万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimizing an mHealth intervention to improve uptake and adherence of the HIV pre-exposure prophylaxis (PrEP) in vulnerable adolescents and emerging adults
优化移动医疗干预措施,以提高弱势青少年和新生成年人对艾滋病毒暴露前预防 (PrEP) 的接受度和依从性
- 批准号:
10311830 - 财政年份:2021
- 资助金额:
$ 26.72万 - 项目类别:
Optimizing an mHealth intervention to improve uptake and adherence of the HIV pre-exposure prophylaxis (PrEP) in vulnerable adolescents and emerging adults
优化移动医疗干预措施,以提高弱势青少年和新生成年人对 HIV 暴露前预防 (PrEP) 的接受度和依从性
- 批准号:
10912991 - 财政年份:2021
- 资助金额:
$ 26.72万 - 项目类别:
Adapting effective mhealth interventions to improve uptake and adherence of the HIV pre- exposure prophylaxis (PrEP) in Thai young MSM
采用有效的移动健康干预措施,以提高泰国年轻 MSM 的 HIV 暴露前预防 (PrEP) 的接受度和依从性
- 批准号:
10440518 - 财政年份:2021
- 资助金额:
$ 26.72万 - 项目类别:
Adapting effective mhealth interventions to improve uptake and adherence of the HIV pre- exposure prophylaxis (PrEP) in Thai young MSM
采用有效的移动健康干预措施,以提高泰国年轻 MSM 的 HIV 暴露前预防 (PrEP) 的接受度和依从性
- 批准号:
10258607 - 财政年份:2021
- 资助金额:
$ 26.72万 - 项目类别:














{{item.name}}会员




